Xenon Stock $42: What to Know Ahead of March Data Outlook
Xenon stock sits at $42 as insiders trim significant positions ahead of a pivotal March Phase 3 readout. This guide b...
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,158 articlesXenon stock sits at $42 as insiders trim significant positions ahead of a pivotal March Phase 3 readout. This guide b...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
A top executive recently disclosed selling a sizable block of Qualys stock. This article explains how to interpret in...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Firms are tightening AI requirements across industries, pushing workers to upskill quickly. This article breaks down ...
Analysts watch Verrica's 2026 earnings for clues on VP-102 sales, cash runway, and pipeline progress. This guide brea...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A clear, investor-focused guide to the IMSR 2025 Earnings Transcript. Learn what the numbers mean for the company’s p...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
AI is advancing the ways fraudsters can tamper with medical records. This feature can ripple into your wallet, credit...